BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3707614)

  • 1. Inhibition of hepatic microsomal drug metabolism by the immunosuppressive agent cyclosporin A.
    Moochhala SM; Renton KW
    Biochem Pharmacol; 1986 May; 35(9):1499-503. PubMed ID: 3707614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.
    Renton KW
    Biochem Pharmacol; 1985 Jul; 34(14):2549-53. PubMed ID: 4015695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on microsomal drug metabolism in man.
    Puurunen J; Sotaniemi E; Pelkonen O
    Eur J Clin Pharmacol; 1980 Aug; 18(2):185-7. PubMed ID: 7428801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver regeneration and hepatic microsomal changes in rats administered cyclosporin A.
    Gershbein LL
    Biochem Pharmacol; 1987 Sep; 36(18):3088-90. PubMed ID: 3632728
    [No Abstract]   [Full Text] [Related]  

  • 6. A class of strong inhibitors of microsomal monooxygenases: the ellipticines.
    Lesca P; Rafidinarivo E; Lecointe P; Mansuy D
    Chem Biol Interact; 1979 Feb; 24(2):189-97. PubMed ID: 428009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of microsomal lipid peroxidation and monooxygenase activities by eugenol.
    Nagababu E; Lakshmaiah N
    Free Radic Res; 1994 Apr; 20(4):253-66. PubMed ID: 8205227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of cytochrome P-450-dependent drug biotransformation by adriamycin.
    Marchand DJ; Renton KW
    Toxicol Appl Pharmacol; 1981 Mar; 58(1):83-8. PubMed ID: 7233442
    [No Abstract]   [Full Text] [Related]  

  • 9. 1-Ethynylpyrene, a suicide inhibitor of cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes.
    Gan LS; Acebo AL; Alworth WL
    Biochemistry; 1984 Aug; 23(17):3827-36. PubMed ID: 6487578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
    Murray M; Hetnarski K; Wilkinson CF
    Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotic biotransformation in wild birds: activity, induction, characterization and comparison with rat and mouse microsomal enzymes.
    Husain MM; Kumar A; Mukhtar H; Krishna Murti CR
    Xenobiotica; 1981 Nov; 11(11):785-93. PubMed ID: 7336760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cyclosporin A an inhibitor of drug metabolism?
    Li G; Treiber G; Meinshausen J; Wolf J; Werringloer J; Klotz U
    Br J Clin Pharmacol; 1990 Jul; 30(1):71-7. PubMed ID: 2390433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
    Kotake AN
    Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes.
    Bertault-Peres P; Bonfils C; Fabre G; Just S; Cano JP; Maurel P
    Drug Metab Dispos; 1987; 15(3):391-8. PubMed ID: 2886317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effect of isoflurane on drug metabolism: decreased type I and increased type II substrate metabolism in guinea pig liver microsomes.
    Rahman MM; Fujii K; Kawamoto M; Yuge O
    J Appl Toxicol; 1996; 16(4):331-7. PubMed ID: 8854220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
    Slusher LB; Park SS; Gelboin HV; Vesell ES
    Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition by carbonyl cyanide m-chlorophenylhydrazone and sodium deoxycholate of cytochrome P-450-catalysed hepatic microsomal drug metabolism.
    Tsyrlov IB; Gromova OA; Lyakhovich VV
    Biochem J; 1976 Oct; 160(1):75-83. PubMed ID: 12746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
    Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP
    Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.